IP Verse

Hetero Labs competitive analysis

Explore the latest publications and patents granted to Hetero Labs, showcasing their recent innovations and technological advancements.

Explore patent oppositions filed by Hetero Labs against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 2, 2025

Patent Number	Title	Applicant	Opposition Date
Get instant updates on new opposition filings by the company
EP3133070	Eliglustat (Genz 112638) As Inhibitor Of Glucosylceramide Synthase For Use In A Method Of Treating Fabry'S Or Gaucher'S Disease, The Method Comprising Adjusting The Individual Therapeutical Dose To The P-450 Metabolism Of The Patient	GENZYME	May 14, 2020

Discover the latest PTAB cases involving Hetero Labs, highlighting their recent legal challenges and patent disputes.

IP litigation analysis comparing Hetero Labs with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced	Strategy Type
HETERO LABS	1	-	-	-	Highly Aggressive
GENZYME	-	19	2	5	Defensive